Tag: Dr Anna M Wu
Telix secures advanced biologics technology platform in strategic deal
Telix Pharmaceuticals has announced an asset purchase agreement with antibody engineering firm ImaginAb, Inc, marking the expansion of its capabilities in precision medicine and therapeutic innovation.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
